Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT06113237 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-05-15
Summary
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
Conditions
- Maternal Complications
- Pregnancy Complication
- Birth Outcomes, Adverse
- Pregnancy
Interventions
- DRUG
-
Epidiolex
Oral solution
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-05
- Primary Completion
- 2033-08-31
- Completion
- 2033-08-31
Countries
- United States
- Germany
Study Locations
More Related Trials
-
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
NCT06258902 ·Status: RECRUITING
-
A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
NCT06710470 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
NCT01566630 ·Status: TERMINATED ·Phase: PHASE2
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
NCT03528967 ·Status: COMPLETED ·Phase: PHASE4
-
Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy
NCT01388322 ·Status: COMPLETED ·Phase: PHASE3
-
Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
NCT04958304 ·Status: TERMINATED
-
Human Papillomavirus (HPV) Infection in Pregnancy
NCT00194311 ·Status: COMPLETED
-
Transplacental Transfer of Drugs Used in Pregnant Women
NCT02622802 ·Status: COMPLETED ·Phase: NA
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
NCT01028183 ·Status: WITHDRAWN
-
Evaluation of Drug's Risk in Pregnant Women
NCT02818842 ·Status: RECRUITING
-
Study to Evaluate the Safety of Repatha® in Pregnancy
NCT02906124 ·Status: TERMINATED
-
Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
NCT00116272 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
NCT03842189 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia
NCT00986765 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone and Pregnancy: Maternal Effects
NCT06259994 ·Status: RECRUITING
-
HYDROxychloroquine in Syndrome Primary AntiPhospholipid
NCT04275778 ·Status: WITHDRAWN ·Phase: PHASE2
-
Development of an International Remote Digital Care System for Accessible, Inclusive and Sustainable Pregnancy Care
NCT07191236 ·Status: ENROLLING_BY_INVITATION
-
Safety of Direct Oral Anticoagulant During Pregnancy
NCT06179823 ·Status: COMPLETED
-
The Eplontersen Pregnancy and Lactation Outcomes Study
NCT07205666 ·Status: RECRUITING
-
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
NCT04063397 ·Status: COMPLETED
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab
NCT03992729 ·Status: RECRUITING
-
Hydroxychloroquine in Type 2 Diabetes During Pregnancy
NCT06319560 ·Status: RECRUITING ·Phase: NA